Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials -- Ignore unavailable to you. Want to Upgrade?

To: scion who wrote (193)	1/22/2003 3:16:42 PM
From: tuck	Respond to of 250

>>BRISBANE, Calif., Jan. 22 /PRNewswire-FirstCall/ -- VaxGen, Inc. (Nasdaq: VXGN - News) reiterated today that it plans to announce the results of its first Phase III trial before the end of March 2003. However, the company does not yet know the outcome of the trial and will not until it has finished its statistical analysis of the trial data. Other than this press release, VaxGen will make no further comment on the trading activity in its stock today. A rumor reported on the Internet today indicated that the company's stock had fallen because the Phase III trial mentioned above had produced unfavorable results. Once again, no data are available yet to conclude if or how effective the vaccine is.<< snip This came out at 3:05. I'm looking for a rebound on which to reshort. It's been a great trader from the $20 area. Cheers, Tuck